Navigation Links
Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
Date:12/20/2010

HORSHAM, Pa., Dec. 20, 2010 /PRNewswire/ -- Centocor Ortho Biotech Inc. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the investigational drug abiraterone acetate administered with prednisone for the treatment of metastatic advanced prostate cancer in patients who have received prior chemotherapy containing a taxane.  Janssen-Cilag International NV also filed a marketing authorization application (MAA) with the European Medicines Agency (EMA) for abiraterone acetate.

Abiraterone acetate was developed by Ortho Biotech Oncology Research & Development, Unit of Cougar Biotechnology, Inc.

Abiraterone acetate is an investigational oral androgen biosynthesis inhibitor being developed for the treatment of metastatic advanced prostate cancer that has developed resistance to conventional hormonal therapies.  This is also known as castration-resistant prostate cancer (CRPC).  It is believed that abiraterone acetate inhibits a key enzyme, CYP17, needed for androgen biosynthesis in the testes, adrenals and tumor.  

Both applications follow completion of a Phase 3, randomized, double-blind, placebo-controlled clinical study (COU-AA-301), which evaluated overall survival and tolerability in patients with metastatic advanced prostate cancer treated with abiraterone acetate plus prednisone compared to treatment with placebo plus prednisone.  In September 2010, the company announced that the study was unblinded on the recommendation of an Independent Data Monitoring Committee.  

Data from this 1,195 patient study conducted in 147 centers in 13 countries were presented at the 35th Annual European Society for Medical Oncology (ESMO) Congress in October 2010.  Additional ongoing studies are currently underway for abiraterone acetate.

"These regulatory file submissions are an important milestone for men with metastatic advanced prostate cancer and for our company,
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
2. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
3. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
4. MD+DI, MPMN, and OrthoTec Announce Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices
5. Ascension Orthopedics Implants PyroTITAN™ in France
6. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
7. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
8. Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016
9. Reportlinker Adds Asia-Pacific Orthopedic Devices Market Outlook to 2016
10. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
11. Ascension Orthopedics Announces Implantation of the TITAN™ Modular Total Shoulder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WOODLANDS, Texas , April 27, 2015   ... biopharmaceutical company focused on developing breakthrough treatments for human ... on Wednesday, April 29, 2015 after the financial markets ... webcast to discuss clinical development progress and financial results ... Time on April 29, 2015. The dial-in ...
(Date:4/27/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that it has received ... Drug Administration ("FDA") verifying that the Company has successfully ... letter it received from the FDA in January 2013. ... March 2015 by the FDA at CryoLife,s manufacturing facility ...
(Date:4/27/2015)... 2015 Numerous Zofran birth defects lawsuits ( ... have highlighted serious concerns surrounding the use of prescription ... the U.S. Centers for Disease Control (CDC), ... have enough information to determine their safety for use ... in the U.S. take at least one medication during ...
Breaking Medicine Technology:Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3
(Date:4/27/2015)... MD (PRWEB) April 27, 2015 Jesse ... the 2015–2020 United States Pharmacopeial Convention (USP) at the ... is Professor of Medicine at Georgetown University and the ... and Stewardship (COMPASS). , As USP President, a volunteer ... Convention Meeting. He will be a voting member, ex ...
(Date:4/27/2015)... MN (PRWEB) April 27, 2015 Based ... Secura Consultants is one of the few insurance marketing ... in the income and asset protection markets as well ... the industry has afforded Secura Consultants the opportunity to ... to make doing business easier and quicker. , An ...
(Date:4/27/2015)... 27, 2015 Array Health , ... has announced that Lance Hood, senior director of marketing, ... annual Direct-to-Consumer Health Care Marketing Summit on ... Smith, Partner and Director of Payer Services, Leavitt Partners, ... consumerism – through a retail/e-commerce perspective – and equip ...
(Date:4/27/2015)... Thanks to a $7.5 million grant from the ... including American University, will operate in a new center ... research aimed at ending the AIDS epidemic. , Nearly ... or AIDS, according to the latest statistics. At the ... the age of 13 was living with HIV, well ...
(Date:4/27/2015)... Sitting or standing for long periods of time ... for those whose occupation requires them to be sitting while ... or to be on their feet for most of the ... more severe and longer lasting. These people suffer from a ... of Northeast Houston Vein Center is offering tips on how ...
Breaking Medicine News(10 mins):Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3
... the latest medicine kings in the treatment of many complex ... in the June issue of Angiology if pine bark extract ... of muscles. ,The reason and scientific basis behind ... to the muscles which speeds recovery after physical exercise. ...
... the chikungunya disease all over the country and in Tamil ... Director, Vector borne Diseases, Tamil Nadu, said today. ... ,Preventive measures are on to restrict the ... a seminar on sensitization programme for medical staff and students ...
... red wines have a sleep inducing ingredient, melatonin. That’s probably the ... hormone is produced by the pineal gland in the brain, which ... hit the sack! , ,The discovery of melatonin in ... bottle in the evening to wind down after a day's hard ...
... receptor activity in the postmortem brain tissue from patients ... of Medicine, in collaboration with scientists at the City ... in its function. A high level of erbB4 receptor ... the receptors in the prefrontal cortex of schizophrenic patient ...
... of subjecting drug addicts to shock therapy as a means ... controversies. Now, the Scottish Executive is doing more research into ... labeled as Neuro-Electric Therapy (NET) is executed with the use ... pulses are sent into the brain. This is known to ...
... center, a tuberculosis case alerts the health authorities //. ... worker, who works at the Centenary Childcare and Early ... ,Dr Michael Whitby, a spokesman of Australian Medical ... the center are at risk of getting infected. ...
Cached Medicine News:Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
... RSV Test utilizes a new, improved format that ... rapid RSV detection. The testing device employs innovative ... reagents have already been applied to the testing ... with clear-cut results shown by the appearance of ...
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: